Haemonetics Corporation (NYSE:HAE) Q2 2022 Earnings Conference Call November 9, 2021 8:00 AM ET Company Participants Olga Guyette - Director, Investor Relations Chris Simon - President and Chief Executive Officer Bill Burke - EVP and Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies Andrew Cooper - Raymond James Drew Ranieri - Morgan Stanley Mike Matson - Needham & Company Operator Good morning ladies and gentlemen, thank you for standing by, and welcome to the Second Quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (State or other jurisdiction of incorporation or organization) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: October 2, 2021 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ☐ 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-28822 ...

Start Time: 08:00 January 1, 0000 8:37 AM ET Haemonetics Corporation (NYSE:HAE) Q1 2022 Earnings Conference Call August 11, 2021, 08:00 AM ET Company Participants Chris Simon - President and CEO Bill Burke - EVP and CFO Olga Guyette - Director, IR Conference Call Participants Anthony Petrone - Jefferies Mike Matson - Needham & Company Drew Ranieri - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Haemonetics First Quarter Fiscal 2022 Conference Call and Webcast. At this time, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ☐ 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organization) 125 Summer Street Boston, Massachusetts 02110 (A ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 3, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorpora ...

Haemonetics Corporation (NYSE:HAE) Q4 2021 Earnings Conference Call May 13, 2021 8:00 AM ET Company Participants Olga Guyette - Director, Investor Relations Chris Simon - Chief Executive Officer Bill Burke - Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies Larry Keusch - Raymond James Larry Solow - CJS Securities Mike Matson - Needham & Company Drew Ranieri - Morgan Stanley Operator Ladies and gentlemen, thank you for standing by and welcome to the Q4 2021 Haemonetics Corpora ...

Haemonetics Corporation (NYSE:HAE) Q3 2021 Results Earnings Conference Call February 2, 2021 8:00 AM ET Company Participants Olga Guyette - Director, Investor Relations Christopher Simon - President and Chief Executive Officer Stewart Strong - President, Global Hospital William Burke - Executive Vice President and Chief Financial Officer Conference Call Participants David Lewis - Morgan Stanley Larry Keusch - Raymond James Anthony Petrone - Jefferies David Turkaly - JMP Securities Mike Matson - Needham & Co ...

Haemonetics' Acquisition of Cardiva Medical February 2, 2021 HAEMONETICS® © 2021 Haemonetics Corporation Forward-Looking Statements and Non-GAAP Financial Measures FORWARD LOOKING STATEMENTS Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements. Forward-looking statements in this presentation may include, without limitation, plans and objectives of management for the operation of Haemonetics Corporation (the "Company"), statements regar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 26, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organizat ...

Haemonetics Corporation (NYSE:HAE) Q2 2021 Earnings Conference Call November 4, 2020 8:00 AM ET Company Participants Olga Guyette - Director of IR Chris Simon - CEO, President & Director Bill Burke - CFO & Executive VP Conference Call Participants Anthony Petrone - Jefferies Larry Keusch - Raymond James David Lewis - Morgan Stanley Dave Turkaly - JMP Securities Mike Matson - Needham & Company Mike Petusky - Barrington Research Operator Ladies and gentlemen, thank you for standing by, and welcome to the Haem ...